Skip to main content

and
  1. No Access

    Article

    Comment on: “Adding Value to CHEERS: New Reporting Standards for Value of Information Analyses”

    Natalia Kunst, Annisa Siu, Michael Drummond in Applied Health Economics and Health Policy (2024)

  2. No Access

    Article

    Cost-Effectiveness and Value of Information Analysis of an Ambient Intelligent Geriatric Management (AmbIGeM) System Compared to Usual Care to Prevent Falls in Older People in Hospitals

    The Ambient Intelligent Geriatric Management (AmbIGeM) system combines wearable sensors with artificial intelligence to trigger alerts to hospital staff before a fall. A clinical trial found no effect across a...

    Clarabelle T. Pham, Renuka Visvanathan in Applied Health Economics and Health Policy (2023)

  3. Article

    Open Access

    Economic Evaluation of Transperineal versus Transrectal Devices for Local Anaesthetic Prostate Biopsies

    Biopsy of the prostate for suspected cancer is usually performed transrectally under local anaesthesia in the outpatient clinic setting. As this involves piercing the bowel wall, the procedure is associated wi...

    Edward C. F. Wilson, Alice Wreford, Priya Tamer, Kelly Leonard in PharmacoEconomics - Open (2021)

  4. No Access

    Article

    Methodological Note: Reporting Deterministic versus Probabilistic Results of Markov, Partitioned Survival and Other Non-Linear Models

    When making decisions under uncertainty, it is reasonable to choose the path that leads to the highest expected net benefit. Therefore, to inform decision making, decision-model-based health economic evaluatio...

    Edward C. F. Wilson in Applied Health Economics and Health Policy (2021)

  5. Article

    Open Access

    Self-Monitoring and Management of Blood Pressure in Patients with Stroke or TIA: An Economic Evaluation of TEST-BP, A Randomised Controlled Trial

    Prevention of secondary stroke following initial ictus is an important focus of after-stroke care. Blood pressure (BP) is a key risk factor, so usual care following stroke or transient ischaemic attack include...

    Lois G. Kim, Edward C. F. Wilson, William J. Davison in PharmacoEconomics - Open (2020)

  6. No Access

    Article

    Transparency in Decision Modelling: What, Why, Who and How?

    Transparency in decision modelling is an evolving concept. Recently, discussion has moved from reporting standards to open-source implementation of decision analytic models. However, in the debate about the su...

    Christopher James Sampson, Renée Arnold, Stirling Bryan, Philip Clarke in PharmacoEconomics (2019)

  7. Article

    Open Access

    The development and feasibility of a randomised family-based physical activity promotion intervention: the Families Reporting Every Step to Health (FRESH) study

    There is a need for high-quality research aiming to increase physical activity in families. This study assessed the feasibility and acceptability of FRESH (Families Reporting Every Step to Health), a child-led...

    Justin M. Guagliano, Helen Elizabeth Brown, Emma Coombes in Pilot and Feasibility Studies (2019)

  8. Article

    Open Access

    DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial

    A key step in the design of a RCT is the estimation of the number of participants needed in the study. The most common approach is to specify a target difference between the treatments for the primary outcome ...

    Jonathan A. Cook, Steven A. Julious, William Sones, Lisa V. Hampson in Trials (2018)

  9. Article

    Open Access

    The Long-Term Cost to the UK NHS and Social Services of Different Durations of IV Thiamine (Vitamin B1) for Chronic Alcohol Misusers with Symptoms of Wernicke’s Encephalopathy Presenting at the Emergency Department

    Wernicke’s encephalopathy (WE) is an acute neuropsychiatric condition caused by depleted intracellular thiamine, most commonly arising in chronic alcohol misusers, who may present to emergency departments (EDs...

    Edward C. F. Wilson, George Stanley in Applied Health Economics and Health Policy (2016)

  10. Article

    Open Access

    The Cost Effectiveness of Maintenance Schedules Following Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease: An Economic Evaluation Alongside a Randomised Controlled Trial

    Chronic obstructive pulmonary disease (COPD) affects approximately 3 million people in the UK. An 8-week pulmonary rehabilitation (PR) course is recommended under current guidelines. However, studies show that...

    Darren K. Burns, Edward C. F. Wilson in Applied Health Economics and Health Policy (2016)

  11. Article

    A Practical Guide to Value of Information Analysis

    Value of information analysis is a quantitative method to estimate the return on investment in proposed research projects. It can be used in a number of ways. Funders of research may find it useful to rank pro...

    Edward C. F. Wilson in PharmacoEconomics (2015)

  12. No Access

    Article

    Treating Idiopathic Pulmonary Fibrosis with the Addition of Co-Trimoxazole: An Economic Evaluation Alongside a Randomised Controlled Trial

    Idiopathic pulmonary fibrosis (IPF) is a fibrotic disease of the lungs of unknown origin with a poor prognosis. A small trial of co-trimoxazole demonstrated improvements in symptoms and functional parameters o...

    Edward C. F. Wilson, Ludmila Shulgina, Anthony P. Cahn in PharmacoEconomics (2014)

  13. No Access

    Article

    Home-Based Medication Review in Older People

    Medication review by pharmacists is increasingly being implemented in the primary care setting and has been incorporated into the new pharmacy contract in the UK. This study aims to determine the cost effectiv...

    Margaret Pacini, Richard D. Smith, Edward C. F. Wilson in PharmacoEconomics (2007)

  14. No Access

    Article

    Using economic analyses for local priority setting

    Standard methods of economic analysis may not be suitable for local decision making that is specific to a particular population.

    Professor Richard F. Heller, Islay Gemmell in Applied Health Economics and Health Policy (2006)

  15. No Access

    Article

    The Cost to the United Kingdom National Health Service of Managing Erectile Dysfunction

    Objective: To estimate the annual direct cost of managing erectile dysfunction (ED) to the UK National Health Service (NHS) and to examine the impact of the introduction of sildenafil in 1998 and...

    Edward C. F. Wilson, Emma S. McKeen, Paul A. Scuffham in PharmacoEconomics (2002)